NCT05906199

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

A Prospective, Randomized, Active-controlled, Parallel, Open, Multi-center, Phase IV, Exploratory Clinical Trial to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract (Renexin CR) and Aspirin (Aspirin Protect Tab.) in Diabetic Peripheral Angiopathy.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: SK Chemicals Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 74 Years
• Healthy volunteers: Not accepted

Summary

This study is to compare and evaluate the effect of improving the carotid IMT and lipid level of the Cilostazol/Ginkgo leaf extract group with the aspirin administrated group in patients with diabetic peripheral angiopathy.

Detailed description

A Prospective, Randomized, Active-controlled, Parallel, Open, Multi-center, Phase IV

Conditions

• Diabetic Peripheral Angiopathy

Interventions

Type	Name	Description
DRUG	Renexin CR 200/160mg	Single oral administration of Renexin CR 200/160mg, QD
DRUG	Aspirin 100mg	Single oral administration of Aspirin 100mg, QD

Timeline

• Start date: 2021-07-28
• Primary completion: 2023-06-23
• Completion: 2023-12-13
• First posted: 2023-06-15
• Last updated: 2025-03-12

Locations

2 sites across 1 country: South Korea